{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:39:19Z","timestamp":1794317959427,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vascular calcification is highly prevalent in end-stage renal diseases and is predictive of cardiovascular events and mortality. Poly(ADP-ribose) polymerase 1 (PARP1) inhibition or deletion is vasoprotective in several disease models. Here we show that PARP activity is increased in radial artery samples from patients with chronic renal failure, in arteries from uraemic rats, and in calcified vascular smooth muscle cells (VSMCs) in vitro. PARP1 deficiency blocks, whereas PARP1 overexpression exacerbates, the transdifferentiation of VSMCs from a contractile to an osteogenic phenotype, the expression of mineralization-regulating proteins, and calcium deposition. PARP1 promotes Runx2 expression, and Runx2 deficiency offsets the pro-calcifying effects of PARP1. Activated PARP1 suppresses miRNA-204 expression via the IL-6\/STAT3 pathway and thus relieves the repression of its target, Runx2, resulting in increased Runx2 protein. Together, these results suggest that PARP1 counteracts vascular calcification and that therapeutic agents that influence PARP1 activity may be of benefit to treat vascular calcification.<\/jats:p>","DOI":"10.1038\/s41467-019-09174-1","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T07:02:46Z","timestamp":1552460566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2"],"prefix":"10.1038","volume":"10","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"9174_CR1","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer, L. L. & Tintut, Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 117, 2938\u20132948 (2008).","journal-title":"Circulation"},{"key":"9174_CR2","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"35","author":"P Lanzer","year":"2014","unstructured":"Lanzer, P. et al. Medial vascular calcification revisited: review and perspectives. Eur. Heart J. 35, 1515\u20131525 (2014).","journal-title":"Eur. Heart J."},{"key":"9174_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff, R., Long, D. A. & Shanahan, C. Mechanistic insights into vascular calcification in CKD. J. Am. Soc. Nephrol. 24, 179\u2013189 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl 1","key":"9174_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1111\/hdi.12084","volume":"17","author":"KL Jablonski","year":"2013","unstructured":"Jablonski, K. L. & Chonchol, M. Vascular calcification in end-stage renal disease. Hemodial. Int. 17(Suppl 1), S17\u2013S21 (2013).","journal-title":"Hemodial. Int."},{"key":"9174_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"SA Steitz","year":"2001","unstructured":"Steitz, S. A. et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 89, 1147\u20131154 (2001).","journal-title":"Circ. Res."},{"key":"9174_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/j.arrt.2004.04.006","volume":"11","author":"Z Al Aly","year":"2004","unstructured":"Al Aly, Z. & Edwards, J. C. Vascular biology in uremia: insights into novel mechanisms of vascular injury. Adv. Chronic Kidney Dis. 11, 310\u2013318 (2004).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"9174_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan, C. M., Crouthamel, M. H., Kapustin, A. & Giachelli, C. M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 109, 697\u2013711 (2011).","journal-title":"Circ. Res."},{"key":"9174_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3810\/pgm.2014.03.2740","volume":"126","author":"MF McCarty","year":"2014","unstructured":"McCarty, M. F. & DiNicolantonio, J. J. The molecular biology and pathophysiology of vascular calcification. Postgrad. Med. 126, 54\u201364 (2014).","journal-title":"Postgrad. Med."},{"key":"9174_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo, X. & Kraus, W. L. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 26, 417\u2013432 (2012).","journal-title":"Genes Dev."},{"key":"9174_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1963","volume":"7","author":"V Schreiber","year":"2006","unstructured":"Schreiber, V., Dantzer, F., Ame, J. C. & de Murcia, G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7, 517\u2013528 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9174_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nchembio.1756","volume":"11","author":"FJ Bock","year":"2015","unstructured":"Bock, F. J. & Chang, P. Stress response: PARP1 911. Nat. Chem. Biol. 11, 179\u2013180 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"9174_CR12","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/MCB.00160-13","volume":"33","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor alpha. Mol. Cell. Biol. 33, 4492\u20134503 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"9174_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0875-4","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang, C., Xu, W., Zhang, Y., Huang, D. & Huang, K. Poly(ADP-ribosyl)ated PXR is a critical regulator of acetaminophen-induced hepatotoxicity. Cell Death Dis. 9, 819 (2018).","journal-title":"Cell Death Dis."},{"key":"9174_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","volume":"25","author":"P Pacher","year":"2007","unstructured":"Pacher, P. & Szabo, C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug. Rev. 25, 235\u2013260 (2007).","journal-title":"Cardiovasc. Drug. Rev."},{"key":"9174_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap, P. & Szabo, C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug. Discov. 4, 421\u2013440 (2005).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"9174_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11684-012-0197-3","volume":"6","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Wang, F., Tang, T. & Guo, C. The role of PARP1 in the DNA damage response and its application in tumor therapy. Front. Med. 6, 156\u2013164 (2012).","journal-title":"Front. Med."},{"key":"9174_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","volume":"24","author":"ND Vaziri","year":"2004","unstructured":"Vaziri, N. D. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol. 24, 469\u2013473 (2004).","journal-title":"Semin. Nephrol."},{"key":"9174_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1523-1755.2003.00702.x","volume":"63","author":"ND Vaziri","year":"2003","unstructured":"Vaziri, N. D., Dicus, M., Ho, N. D., Boroujerdi-Rad, L. & Sindhu, R. K. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 63, 179\u2013185 (2003).","journal-title":"Kidney Int."},{"key":"9174_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bbrc.2012.03.064","volume":"420","author":"E Nagy","year":"2012","unstructured":"Nagy, E., Caidahl, K., Franco-Cereceda, A. & Back, M. Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity. Biochem. Biophys. Res. Commun. 420, 671\u2013675 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9174_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCRESAHA.116.310060","volume":"120","author":"JD Hutcheson","year":"2017","unstructured":"Hutcheson, J. D., Blaser, M. C. & Aikawa, E. Giving Calcification Its Due: Recognition of a Diverse Disease: A First Attempt to Standardize the Field. Circ. Res. 120, 270\u2013273 (2017).","journal-title":"Circ. Res."},{"key":"9174_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/CIRCRESAHA.112.267237","volume":"111","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ. Res. 111, 543\u2013552 (2012).","journal-title":"Circ. Res."},{"key":"9174_CR22","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.ajpath.2015.03.020","volume":"185","author":"ME Lin","year":"2015","unstructured":"Lin, M. E., Chen, T., Leaf, E. M., Speer, M. Y. & Giachelli, C. M. Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice. Am. J. Pathol. 185, 1958\u20131969 (2015).","journal-title":"Am. J. Pathol."},{"key":"9174_CR23","doi-asserted-by":"crossref","unstructured":"Lin, M. E. et al. Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation. Cardiovasc. Res. 112, 606\u2013616 (2016).","DOI":"10.1093\/cvr\/cvw205"},{"key":"9174_CR24","doi-asserted-by":"publisher","first-page":"15319","DOI":"10.1074\/jbc.M800021200","volume":"283","author":"CH Byon","year":"2008","unstructured":"Byon, C. H. et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J. Biol. Chem. 283, 15319\u201315327 (2008).","journal-title":"J. Biol. Chem."},{"key":"9174_CR25","doi-asserted-by":"crossref","unstructured":"Jun, J. H. et al. BMP2-activated Erk\/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J. Biol. Chem. 285, 36410\u201336419 (2010).","DOI":"10.1074\/jbc.M110.142307"},{"key":"9174_CR26","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur, T. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280, 33132\u201333140 (2005).","journal-title":"J. Biol. Chem."},{"key":"9174_CR27","doi-asserted-by":"publisher","first-page":"9863","DOI":"10.1073\/pnas.1018493108","volume":"108","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc. Natl Acad. Sci. USA 108, 9863\u20139868 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9174_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/00041552-200311000-00004","volume":"12","author":"J Himmelfarb","year":"2003","unstructured":"Himmelfarb, J. & Hakim, R. M. Oxidative stress in uremia. Curr. Opin. Nephrol. Hypertens. 12, 593\u2013598 (2003).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"9174_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/jbmr.539","volume":"27","author":"S Yamada","year":"2012","unstructured":"Yamada, S. et al. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J. Bone Miner. Res. 27, 474\u2013485 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"9174_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1161\/CIRCRESAHA.110.234328","volume":"108","author":"Y Du","year":"2011","unstructured":"Du, Y. et al. Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ. Res. 108, 917\u2013928 (2011).","journal-title":"Circ. Res."},{"key":"9174_CR31","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ki.2012.482","volume":"83","author":"XY Dai","year":"2013","unstructured":"Dai, X. Y. et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 83, 1042\u20131051 (2013).","journal-title":"Kidney Int."},{"key":"9174_CR32","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.2337\/db14-0326","volume":"63","author":"SL Cheng","year":"2014","unstructured":"Cheng, S. L. et al. Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets. Diabetes 63, 4326\u20134337 (2014).","journal-title":"Diabetes"},{"key":"9174_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jb\/mvs004","volume":"151","author":"R Nishimura","year":"2012","unstructured":"Nishimura, R., Hata, K., Matsubara, T., Wakabayashi, M. & Yoneda, T. Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J. Biochem. 151, 247\u2013254 (2012).","journal-title":"J. Biochem."},{"key":"9174_CR34","first-page":"10386","volume":"44","author":"L Rank","year":"2016","unstructured":"Rank, L. et al. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 44, 10386\u201310405 (2016).","journal-title":"Nucleic Acids Res."},{"key":"9174_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.1216338","volume":"336","author":"MF Langelier","year":"2012","unstructured":"Langelier, M. F., Planck, J. L., Roy, S. & Pascal, J. M. Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1. Science 336, 728\u2013732 (2012).","journal-title":"Science"},{"key":"9174_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","volume":"60","author":"JM Dawicki-McKenna","year":"2015","unstructured":"Dawicki-McKenna, J. M. et al. PARP-1 activation requires local unfolding of an autoinhibitory domain. Mol. Cell 60, 755\u2013768 (2015).","journal-title":"Mol. Cell"},{"key":"9174_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ki.2015.160","volume":"88","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation. Kidney Int. 88, 711\u2013721 (2015).","journal-title":"Kidney Int."},{"key":"9174_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-155","volume":"12","author":"W Bao","year":"2013","unstructured":"Bao, W. et al. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol. Cancer 12, 155 (2013).","journal-title":"Mol. Cancer"},{"key":"9174_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.arcmed.2008.09.003","volume":"39","author":"D Huang","year":"2008","unstructured":"Huang, D. et al. Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-alpha and IL-6 expression in patients with unstable angina. Arch. Med. Res. 39, 775\u2013784 (2008).","journal-title":"Arch. Med. Res."},{"key":"9174_CR40","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1016\/j.ajpath.2016.08.016","volume":"186","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Inhibition of poly(ADP-Ribose) polymerase-1 protects chronic alcoholic liver injury. Am. J. Pathol. 186, 3117\u20133130 (2016).","journal-title":"Am. J. Pathol."},{"key":"9174_CR41","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ijcard.2012.06.050","volume":"167","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. Int. J. Cardiol. 167, 2285\u20132293 (2013).","journal-title":"Int. J. Cardiol."},{"key":"9174_CR42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/CIRCULATIONAHA.113.006167","volume":"129","author":"J Meloche","year":"2014","unstructured":"Meloche, J. et al. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation 129, 786\u2013797 (2014).","journal-title":"Circulation"},{"key":"9174_CR43","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1161\/CIRCRESAHA.111.300543","volume":"112","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Drozdov, I., Shroff, R., Beltran, L. E. & Shanahan, C. M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112, e99\u2013e109 (2013).","journal-title":"Circ. Res."},{"key":"9174_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20101812","volume":"208","author":"A Courboulin","year":"2011","unstructured":"Courboulin, A. et al. Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 208, 535\u2013548 (2011).","journal-title":"J. Exp. Med."},{"key":"9174_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ki.2012.40","volume":"82","author":"G Zhao","year":"2012","unstructured":"Zhao, G. et al. Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int. 82, 34\u201344 (2012).","journal-title":"Kidney Int."},{"key":"9174_CR46","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ki.2010.548","volume":"79","author":"Z Al-Aly","year":"2011","unstructured":"Al-Aly, Z. Phosphate, oxidative stress, and nuclear factor-kappaB activation in vascular calcification. Kidney Int. 79, 1044\u20131047 (2011).","journal-title":"Kidney Int."},{"key":"9174_CR47","doi-asserted-by":"crossref","unstructured":"Zhao, M. M., et al. Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int. 79, 1071\u20131079 (2011).","DOI":"10.1038\/ki.2011.18"},{"key":"9174_CR48","doi-asserted-by":"crossref","unstructured":"Yoshida, T., Yamashita, M., Horimai, C & Hayashi, M. Smooth muscle-selective nuclear factor-kappaB inhibition reduces phosphate-induced arterial medial calcification in mice with chronic kidney disease. J. Am. Heart. Assoc. 6, pii: e007248 (2017).","DOI":"10.1161\/JAHA.117.007248"},{"key":"9174_CR49","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1016\/j.febslet.2012.09.026","volume":"586","author":"P Bai","year":"2012","unstructured":"Bai, P. & Virag, L. Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Lett. 586, 3771\u20133777 (2012).","journal-title":"FEBS Lett."},{"key":"9174_CR50","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1515\/BC.1999.118","volume":"380","author":"PO Hassa","year":"1999","unstructured":"Hassa, P. O. & Hottiger, M. O. A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380, 953\u2013959 (1999).","journal-title":"Biol. Chem."},{"key":"9174_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/brb3.239","volume":"4","author":"RI Martinez-Zamudio","year":"2014","unstructured":"Martinez-Zamudio, R. I. & Ha, H. C. PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia. Brain Behav. 4, 552\u2013565 (2014).","journal-title":"Brain Behav."},{"key":"9174_CR52","doi-asserted-by":"crossref","unstructured":"Schroeder, T. M., Kahler, R. A., Li, X., Westendorf, J. J. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 279, 41998\u201342007 (2004).","DOI":"10.1074\/jbc.M403702200"},{"key":"9174_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajpath.2013.03.007","volume":"183","author":"AK Sowa","year":"2013","unstructured":"Sowa, A. K. et al. Functional interaction of osteogenic transcription factors Runx2 and Vdr in transcriptional regulation of Opn during soft tissue calcification. Am. J. Pathol. 183, 60\u201368 (2013).","journal-title":"Am. J. Pathol."},{"key":"9174_CR54","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jcb.10677","volume":"90","author":"MH Drissi","year":"2003","unstructured":"Drissi, M. H. et al. Runx2\/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J. Cell. Biochem. 90, 1287\u20131298 (2003).","journal-title":"J. Cell. Biochem."},{"key":"9174_CR55","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/ATVBAHA.116.308606","volume":"37","author":"N Shi","year":"2017","unstructured":"Shi, N., Li, C. X., Cui, X. B., Tomarev, S. I. & Chen, S. Y. Olfactomedin 2 regulates smooth muscle phenotypic modulation and vascular remodeling through mediating runt-related transcription factor 2 binding to serum response factor. Arterioscler. Thromb. Vasc. Biol. 37, 446\u2013454 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9174_CR56","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1161\/ATVBAHA.110.204834","volume":"30","author":"E Neven","year":"2010","unstructured":"Neven, E. et al. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler. Thromb. Vasc. Biol. 30, 1741\u20131750 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9174_CR57","doi-asserted-by":"crossref","unstructured":"Xu W. et al. A20 prevents obesity-induced development of cardiac dysfunction. J. Mol. Med. (Berl) 96, 159\u2013172 (2017).","DOI":"10.1007\/s00109-017-1608-3"},{"key":"9174_CR58","doi-asserted-by":"crossref","unstructured":"Wang, C., Xu W., Liang, M., Huang, D., Huang, K. CTRP13 inhibits atherosclerosis via autophagy-lysosome-dependent degradation of CD36. FASEB J. 33, 2290\u20132300 (2019).","DOI":"10.1096\/fj.201801267RR"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09174-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:26:06Z","timestamp":1671207966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9174"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09174-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1203"}}